[Gly14]-Humanin improved the learning and memory impairment induced by scopolamine in vivo

被引:104
作者
Mamiya, T [1 ]
Ukai, M [1 ]
机构
[1] Meijo Univ, Fac Pharmaceut Sci, Dept Chem Pharmacol, Tempaku Ku, Nagoya, Aichi 4688503, Japan
关键词
humanin; Gly(14)]-humanin; Alzheimer's disease; learning and memory; Y-maze test;
D O I
10.1038/sj.bjp.0704429
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Humanin is a very recently discovered 24 amino acid linear polypeptide, which protects against cell death induced by either familial Alzheimer's disease mutant of amyloid precursor protein, presenilin-1 or presenilin-2 in vitro. However, it has remained uncertain whether humanin is a useful drug for the animal model of learning and memory deficit. In this study. we evaluated the effects of [Gly(14)]-humanin, a more potent humanin analogue, on the scopolamine HBr (1 mg kg(-1) s.c.)-induced impairment of spontaneous alternation behaviour in the Y-maze, an index of short-term memory in mice. [Gly(14)]-Humanin (1000 pmol 5 mul(-1) i.c.v.) reversed the impairment without affecting the number of arm entries. These results suggest that (I) [Gly(14)]-humanin is a beneficial drug for the impairment of learning and memory and (II) it modulates the learning and memory function mediated via cholinergic systems in mice.
引用
收藏
页码:1597 / 1599
页数:3
相关论文
共 12 条
  • [1] THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION
    BARTUS, RT
    DEAN, RL
    BEER, B
    LIPPA, AS
    [J]. SCIENCE, 1982, 217 (4558) : 408 - 417
  • [2] A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ
    Hashimoto, Y
    Niikura, T
    Tajima, H
    Yasukawa, T
    Sudo, H
    Ito, Y
    Kita, Y
    Kawasumi, M
    Kouyama, K
    Doyu, M
    Sobue, G
    Koide, T
    Tsuji, S
    Lang, JC
    Kurokawa, K
    Nishimoto, I
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (11) : 6336 - 6341
  • [3] Mechanisms of neuroprotection by a novel rescue factor humanin from Swedish mutant amyloid precursor protein
    Hashimoto, Y
    Ito, Y
    Niikura, T
    Shao, Z
    Hata, M
    Oyama, F
    Nishimoto, I
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 283 (02) : 460 - 468
  • [4] Nociceptin orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice
    Hiramatsu, M
    Inoue, K
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (03) : 655 - 660
  • [5] Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous κ-opioid receptor agonist
    Hiramatsu, M
    Murasawa, H
    Mori, H
    Kameyama, T
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (05) : 920 - 926
  • [6] KOVACS GL, 1994, PHARMACOL REV, V46, P269
  • [7] Effects of sigma receptor agonists on the impairment of spontaneous alternation behavior and decrease of cyclic GMP level induced by nitric oxide synthase inhibitors in mice
    Mamiya, T
    Noda, Y
    Noda, A
    Hiramatsu, M
    Karasawa, K
    Kameyama, T
    Furukawa, S
    Yamada, K
    Nabeshima, T
    [J]. NEUROPHARMACOLOGY, 2000, 39 (12) : 2391 - 2398
  • [8] SA4503, a novel cognitive enhancer with sigma(1) receptor agonist properties, facilitates NMDA receptor-dependent learning in mice
    Maurice, T
    Privat, A
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 328 (01) : 9 - 18
  • [9] Newhouse P A, 1990, Adv Exp Med Biol, V282, P65
  • [10] ATTENUATION OF SCOPOLAMINE-INDUCED IMPAIRMENT OF SPONTANEOUS-ALTERNATION BEHAVIOR BY ANTAGONIST BUT NOT INVERSE AGONIST AND AGONIST BETA-CARBOLINES
    SARTER, M
    BODEWITZ, G
    STEPHENS, DN
    [J]. PSYCHOPHARMACOLOGY, 1988, 94 (04) : 491 - 495